✦ LIBER ✦

Resource Utilization and Costs of Schizophrenia Patients Treated with Olanzapine versus Quetiapine in a Medicaid Population

✍ Scribed by Andrew P. Yu; Pavel Atanasov; Rym Ben-Hamadi; Howard Birnbaum; Michael D. Stensland; Glenn Philips

Book ID: 109078954
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 91 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1111/j.1524-4733.2008.00498.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quetiapine versus olanzapine for the tre

Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia

✍ Pinkhas Sirota; Irit Pannet; Ady Koren; Eleonora Tchernichovsky 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract Negative symptoms are considered the most debilitating and refractory aspect of schizophrenia, being associated with poor social, occupational and global outcomes. Conventional antipsychotics have limited efficacy against these symptoms and poor tolerability profiles. Atypical antipsych

Outcomes and Costs of Risperidone versus

Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model

✍ Montserrat Vera-Llonch; Thomas E Delea; Erin Richardson; Marcia Rupnow; Amy Grog 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Efficacy and tolerability of quetiapine

Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone

✍ Ilkka Larmo; André de Nayer; Elmar Windhager; Irmansyah; Bernhard Lindenbauer; H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract A __post hoc__ analysis of the SPECTRUM trial was carried out to evaluate whether the improvements in efficacy and tolerability gained on switching to quetiapine occurred consistently for patients previously treated with either: haloperidol (__n__ = 43); olanzapine (__n__ = 66); or risp

Long-term medical costs and resource uti

Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: A five-year analysis of a large medicaid population

✍ Li, Tracy ;Carls, Ginger Smith ;Panopalis, Pantelis ;Wang, Sara ;Gibson, Teresa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB 👁 1 views

Comparison of metabolic changes in patie

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine

✍ David P. McDonnell; Ludmila A. Kryzhanovskaya; Fangyi Zhao; Holland C. Detke; Pe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Metabolic changes were examined in patients with schizophrenia during treatment with either oral olanzapine or olanzapine long‐acting injection (LAI). Data were collected from patients who had been stabilized on oral olanzapine (10, 15, or 20 mg/day) for ≥4 weeks and then randomized to either contin

Comments to the Editor on “Outcomes and

Comments to the Editor on “Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model”

📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB